Krilogy Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Krilogy Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6M	Buy	79,817 +69,426	+668%	+$9.39M	0.37%	51
2026 Q1	$1.41M	Sell	10,391 -50,716	-83%	-$6.33M	0.05%	279
2025 Q4	$7.81M	Buy	+61,107	New	+$7.01M	0.27%	67
2024 Q4	–	Sell	-16,639	Closed	-$1.64M	–	233
2024 Q3	$1.64M	Buy	+16,639	New	+$1.63M	0.11%	134
2018 Q4	–	Sell	-234	Closed	-$22K	–	691
2018 Q3	$22K	Buy	+234	New	+$22.7K	0.01%	415
2018 Q2	–	Sell	-234	Closed	-$21K	–	639
2018 Q1	$21K	Hold	234	–	–	0.01%	438
2017 Q4	$20K	Hold	234	–	–	﹤0.01%	429
2017 Q3	$20K	Buy	234 +1	+0.4%	+$80	0.01%	475
2017 Q2	$18K	Hold	233	–	–	0.01%	453
2017 Q1	$14K	Hold	233	–	–	﹤0.01%	474
2016 Q4	$14K	Hold	233	–	–	﹤0.01%	474
2016 Q3	$15K	Hold	233	–	–	﹤0.01%	475
2016 Q2	$13K	Hold	233	–	–	﹤0.01%	495
2016 Q1	$12K	Buy	233 +58	+33%	+$3.01K	﹤0.01%	456
2015 Q4	$12K	Buy	175 +106	+154%	+$7.23K	0.01%	244
2015 Q3	$4K	Buy	+69	New	+$5.44K	﹤0.01%	496

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Krilogy Financial's XBI Position: Q2 2026 in Review

Krilogy Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 668% in Q2 2026, buying an estimated $9.39M and bringing the position to 79,817 shares worth $12.6M. The position accounts for 0.37% of the portfolio, ranked #51.

Krilogy Financial first reported a position in XBI in Q3 2015 and has held it in 16 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Krilogy Financial held 79,817 shares of State Street SPDR S&P Biotech ETF worth $12.6M as of Q2 2026.
Krilogy Financial bought 69,426 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $9.39M.
State Street SPDR S&P Biotech ETF made up 0.37% of Krilogy Financial's portfolio in Q2 2026, its #51 holding.
Krilogy Financial first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 16 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.